Home / Research projects / PSC- DS COPDefence 21 - An Adaptive Interventional Clinical Investigation to Evaluate the Efficacy and Safety of PulmonYDEFENCE in supporting the prevention of exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.
Share
PSC- DS COPDefence 21 - An Adaptive Interventional Clinical Investigation to Evaluate the Efficacy and Safety of PulmonYDEFENCE in supporting the prevention of exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.
Project objectives
Primary objective
To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations.
Secondary objectives
To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations by standard therapy.
To evaluate the performance of PolmonYDEFENCE in supporting the prevention of exacerbations.
To evaluate the performance of PolmonYDEFENCE in improving the health-related quality of life (HRQoL).
To evaluate the safety and tolerability of PulmonYDEFENCE. • To evaluate patient's satisfaction with PulmonYDEFENCE